Therapeutic Oligonucleotides Targeting Liver Disease: TTR Amyloidosis - Wikidata - wikimedia - TriplyDB

Therapeutic Oligonucleotides Targeting Liver Disease: TTR Amyloidosis

Therapeutic Oligonucleotides Targeting Liver Disease: TTR Amyloidosis

http://www.wikidata.org/entity/Q26782089

about

Corino de Andrade disease: mechanisms and impact on reproduction.Evaluation of Therapeutic Oligonucleotides for Familial Amyloid Polyneuropathy in Patient-Derived Hepatocyte-Like Cells.Bolaamphiphile-based nanocomplex delivery of phosphorothioate gapmer antisense oligonucleotides as a treatment for Clostridium difficile.Gene-targeting pharmaceuticals for single-gene disorders.Addressing Common Questions Encountered in the Diagnosis and Management of Cardiac Amyloidosis.A Peptide-Fc Opsonin with Pan-Amyloid Reactivity Suppressing transthyretin production in mice, monkeys and humans using 2nd-Generation antisense oligonucleotides.Making sense of antisense oligonucleotides: A narrative review.Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs.

P2860

Q33807480-8DC93C55-CBE3-4E34-9F9A-04C49942E698 Q36120100-5B7E76BD-D5ED-430C-A1A8-8E45D2E4DA80 Q38291228-B33BD036-3946-464E-9404-D87D2581D7A4 Q38656342-005B384A-9D1C-4846-BB97-57BDE2CD300B Q39217713-B96CFAA3-B701-4CFC-8445-515036DEFE93 Q41471564-5C8B6827-E11F-4EF1-9EA7-5956E93F6467 Q46476158-4BC0F239-63BB-48CE-9FC1-7B3E3E25F7ED Q47438944-ECC82938-009C-409E-A779-15B127887E19 Q48569299-522AAD9D-34DC-49EC-A656-7C485E6CA09B

P2860

Therapeutic Oligonucleotides Targeting Liver Disease: TTR Amyloidosis

http://www.wikidata.org/entity/Q26782089

description

2015 nî lūn-bûn

@nan

2015 թուականին հրատարակուած գիտական յօդուած

@hyw

2015 թվականին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

name

Therapeutic Oligonucleotides Targeting Liver Disease: TTR Amyloidosis

@ast

Therapeutic Oligonucleotides Targeting Liver Disease: TTR Amyloidosis

@en

Therapeutic Oligonucleotides Targeting Liver Disease: TTR Amyloidosis

@nl

type

label

Therapeutic Oligonucleotides Targeting Liver Disease: TTR Amyloidosis

@ast

Therapeutic Oligonucleotides Targeting Liver Disease: TTR Amyloidosis

@en

Therapeutic Oligonucleotides Targeting Liver Disease: TTR Amyloidosis

@nl

prefLabel

Therapeutic Oligonucleotides Targeting Liver Disease: TTR Amyloidosis

@ast

Therapeutic Oligonucleotides Targeting Liver Disease: TTR Amyloidosis

@en

Therapeutic Oligonucleotides Targeting Liver Disease: TTR Amyloidosis

@nl

P1433

Q26782089-4B1A3780-722E-4DB8-89C1-EA88FA82B69F

P1476

Q26782089-F8A938FD-D46B-417A-9DB5-8107F6E63A4F

P2093

Q26782089-6A312A72-FAD6-46CC-9A37-773A2DDA0BE2

P2860

Q26782089-0400E7F1-CCD0-42F1-9A1E-30593D0A41FE

Q26782089-0705BBB8-BA47-4644-8CA6-37B3F4760BE1

Q26782089-080311DD-9FD9-4A53-A4F2-4075B713BF9A

Q26782089-094834FC-8EC6-453B-9665-B28DE4CBF207

Q26782089-09F638B0-3693-4461-8202-C4EEC7E9641F

Q26782089-0A0A64C6-2749-430A-B73C-54CB42CFA75C

Q26782089-0A9F15F2-A544-4628-A744-90A07A3E17AF

Q26782089-0DF160CB-3F97-4B53-A628-AEA431C30031

Q26782089-107A8991-5BCD-4F0F-85D6-E03F15B55E43

Q26782089-11073A23-4126-4C60-9BFB-302644E06AAB

P304

Q26782089-9633A9E9-B076-4F97-BC43-F11844318665

P31

Q26782089-79CAD3D0-A5BC-4F97-976C-EE6F5324B8CA

P3181

Q26782089-BAB02428-C3E9-4A9A-B014-2C6157A706BB

P356

Q26782089-BEB1643B-41B2-4495-9F3B-1A848C72AACD

P407

Q26782089-C485A02D-CF41-4A22-BFD9-99DB932BADD2

P433

Q26782089-C19E63BC-A675-4262-A71B-38BD24292A7D

P478

Q26782089-737922F8-EE20-4BCE-B399-D6E767634725

P50

Q26782089-25181384-7791-4725-9AFD-CBA80D84B6C0

Q26782089-69A8482B-5547-46DD-9C73-F224BA07B6C1

P577

Q26782089-43830A80-E299-401B-B69C-C920B8EE6E8F

P5875

Q26782089-67957EAE-71B4-4D7E-BD2C-ECDA34AF6414

P698

Q26782089-0DEAFD7B-C00C-4EE5-A889-74CA7BF049B3

P932

Q26782089-0C222D50-5A0B-44AB-8734-A2FA7AA504BD

P3181

P356

MOLECULES201017944

P1433

P1476

Therapeutic Oligonucleotides Targeting Liver Disease: TTR Amyloidosis

@en

P2093

Gursimran Chandhok

http://www.w3.org/2001/XMLSchema#string

P2860

Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7

Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs

Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imaging

Antisense mediated splicing modulation for inherited metabolic diseases: challenges for delivery

Insights into RNA/DNA hybrid recognition and processing by RNase H from the crystal structure of a non-specific enzyme-dsDNA complex

Argonaute2 is the catalytic engine of mammalian RNAi

RNA interference is mediated by 21- and 22-nucleotide RNAs

Role for a bidentate ribonuclease in the initiation step of RNA interference

Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

Functional siRNAs and miRNAs exhibit strand bias

P304

17944-17975

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3754440

http://www.w3.org/2001/XMLSchema#string

P356

10.3390/MOLECULES201017944

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

Hartmut H-J Schmidt

Christoph Niemietz

P577

2015-09-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282609186

http://www.w3.org/2001/XMLSchema#string

P698

26437390

http://www.w3.org/2001/XMLSchema#string

P932

6332041

http://www.w3.org/2001/XMLSchema#string